REPRO-MED Systems (KRMD) Gets a Buy from Lake Street
Lake Street analyst Frank Takkinen reiterated a Buy rating on REPRO-MED Systems (KRMD – Research Report) today and set a price target of $6.00.
Hosted on MSN5d
Piper Sandler Downgrades KORU Medical Systems (KRMD)
Fintel reports that on February 14, 2025, Piper Sandler downgraded their outlook for KORU Medical Systems (NasdaqCM:KRMD) ...
KORU Medical Systems Has A Long Runway
The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...
Craig-Hallum Remains a Buy on REPRO-MED Systems (KRMD)
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on REPRO-MED Systems (KRMD – Research Report) today. The company’s shares ...
ETF Daily News5d
KORU Medical Systems’ (KRMD) “Neutral” Rating Reaffirmed at Piper Sandler
Shares of NASDAQ:KRMD opened at $4.37 on Friday. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $200.31 ...
Yahoo Finance27d
KORU Medical Systems Inc. (KRMD) is a Great Momentum Stock: Should You Buy?
Below, we take a look at KORU Medical Systems Inc. (KRMD), a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the ...
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...